Controversy and quality improvement: lingering questions about ethics, oversight, and patient safety research

Nancy Kass; Peter J Pronovost; Jeremy Sugarman; Christine A Goeschel; Lisa H Lubomski; Ruth Faden

doi:10.1016/s1553-7250(08)34044-6

Controversy and quality improvement: lingering questions about ethics, oversight, and patient safety research

Jt Comm J Qual Patient Saf. 2008 Jun;34(6):349-53. doi: 10.1016/s1553-7250(08)34044-6.

Authors

Nancy Kass¹, Peter J Pronovost, Jeremy Sugarman, Christine A Goeschel, Lisa H Lubomski, Ruth Faden

Affiliation

¹ Berman Institute of Biothics, Department of Health Policy and Management, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, USA. nkass@jhsph.edu

PMID: 18595381
DOI: 10.1016/s1553-7250(08)34044-6

Abstract

Six ethical and regulatory issues are relevant to the Michigan ICU safety program and checklist and to evidence-based patient safety initiatives in general.

MeSH terms

Confidentiality / ethics*
Ethics, Research*
Evidence-Based Medicine / ethics
Hospitals / ethics*
Humans
Infection Control
Michigan
Safety Management*